Find information on thousands of medical conditions and prescription drugs.

Ofloxacin

Ofloxacin sold under the brand name Floxin in the US. It is a quinolone antibiotic. Ofloxacin is the racemic mixture of the chiral compound. The biologically active enantiomer is sold separately under the name of levofloxacin. It is an alternative treatment to ciprofloxacin for anthrax.

Home

OCL

Oncovin

Opium

Oratane

Oretic

Orinase

Oruvail

Ovcon

Ovral

Ovrette

Oxetine

Read more at Wikipedia.org

• [List your site here Free!]


	Ofloxacin in Compromised Host (International Ofloxacin Symposium, July 12, 1990) $37.62	Ototopical antibiotic good for AOM with tubes. (Topical Lacks side Effects of Systemic Tx).(acute otitis media) : An article from: Pediatric News $5.95

	Otic antibiotic as effective as systemic otitis Tx. (Spares Patients Adverse Effects, Diarrhea).(treatment) : An article from: Family Practice News $5.95


Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis : preliminary results of a retrospective study from Objective: To compare levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis (MDR-TB). Patients and methods: A retrospective ... From CHEST, 10/1/03 by Wing Wai Yew

Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors Study objectives: To evaluate the efficacy and tolerability of levofloxacin (L) as monotherapy in patients with severe community-acquired pneumonia (CAP) in comparison with therapy using a combinat From CHEST, 7/1/05 by Olivier Leroy

Ofloxacin 0.5% Topical Liquid METHOD OF PREPARATION 1. Calculate the required quantity of each ingredient for the total amount to be prepared. 2. Accurately weigh and/or measure each ... From International Journal of Pharmaceutical Compounding, 11/1/04

Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/ Levofloxacin-Containing Regimens - ) Objective: To analyze outcomes of patients with multidrug-resistant tuberculosis (MDR-TB) treated with ofloxacin/levofloxacin-containing regimens. Materials and methods: From February 1990 throug From CHEST, 3/1/00 by Wing Wai Yew

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative Study objective: Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB). From CHEST, 7/1/98 by C. Andrew DeAbate

A Mycobacterium leprae isolate resistant to dapsone, Rifampin, Ofloxacin and Sparfloxacin A Mycobacterium leprae Isolate Resistant to Dapsone, Rifampin, Ofloxacin and Sparfloxacin1 Since dapsone (DDS) was introduced for leprosy treatment, many effective antileprosy drugs have been added From International Journal of Leprosy and Other Mycobacterial Diseases, 12/1/00 by Matsuoka, Masanori

Evaluation of various methods of susceptibility to ofloxacin in strains of Mycobacterium tuberculosis Accepted December 3, 1999 A comparison of three methods of susceptibility testing was undertaken on 30 susceptible and 25 resistant strains of Mycobacterium ... From Indian Journal of Medical Research, 12/1/99 by Sulochana, S

Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis Ofloxacin is a new quinolone antimicrobial with a broad spectrum of activity for Gram-positive and Gram-negative bacteria, Legionella species,[1] Mycoplasma ... From CHEST, 12/1/92 by Shigeru Kohno

Home

Contact

Resources

Exchange Links

ebay